SVA [SINOVAC BIOTECH] 6-K: Sinovac Receives Clinical Trial Approval for Varicella Vaccine

[Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate BEIJING, Oct. 26, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac Dalian, has received approval to begin human clinical trials on its varicella vaccine candidate. The clinical trial application for the varicella vaccine was officially accepted] []

By | 2016-03-16T06:19:06+00:00 November 2nd, 2015|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

VIMC [Vimicro International] 6-K: Vimicro Announces Departure of Chief Financial Officer BEIJING,

[Vimicro Announces Departure of Chief Financial Officer BEIJING, November 2, 2015 /PRNewswire/ -- Vimicro International Corporation (NASDAQ: VIMC) (“Vimicro” or the “Company”), a leading video surveillance technology and solution provider in China, today announced that Mr. Peter Li, CFO of the Company, has resigned from the Company due to personal reasons, effective October 31, 2015. “Peter has been a great] []

By | 2016-03-22T19:23:17+00:00 November 2nd, 2015|Categories: Chinese Stocks, VIMC, Webplus ver|Tags: , , , , , |0 Comments
Read More

YZC [YANZHOU COAL MINING CO] 6-K: Yanzhou Coal Mining Company Limited Date November 2,

[Yanzhou Coal Mining Company Limited Date November 2, 2015 By Zhang Baocai Director and Company Secretary For Main Board and GEM listed issuers Monthly Return of Equity Issuer on Movements in Securities]

By | 2016-03-23T01:34:36+00:00 November 2nd, 2015|Categories: Chinese Stocks, Webplus ver, YZC|Tags: , , , , , |0 Comments
Read More

MCOX [Mecox Lane] SC 13D: (Original Filing)

[JOINT FILING AGREEMENT Dated: October 31, 2015 ChinaEquity USD Fortune Co., Ltd. ChinaEquity USD Fund I L.P. ChinaEquity USD Investment GP L.P. ChinaEquity USD Investment Management Co. ChinaEquity Global Holding Co., Ltd. Chaoyong Wang Xu Wang] [July 21, 2015 Company The Board of Directors Dear Sirs and Madams: CNshangquan Leading Capital Consortium Members Transaction We, CNshangquan Limited (“ We believe our proposal provides a very attractive opportunity to the Company’s shareholders. Our proposal represents a premium of approximately 17.6% to the Company’s closing price on July 20, 2015. We are confident that the Transaction can be] [AMENDED AND RESTATED CONSORTIUM AGREEMENT Agreement CNshangquan Leading Capital ChinaEquity Party Parties THIS AMENDED AND RESTATED CONSORTIUM AGREEMENT is made on October 26, 2015 (the “ Original Consortium Agreement Proposal Target Board Target Transaction Exchange Act WHEREAS, on July 21, 2015, CNshangquan and Leading Capital have entered into a Consortium Agreement (the “ WHEREAS, ChinaEquity intended to participate in the] [ChinaEquity USD Fortune Co., Ltd. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨ 3. SEC Use Only 4. Source of Funds (See Instructions) OO 5. ¨ Number of 6. Citizenship or Place of Organization British Virgin Islands Beneficially Owned by 7. Sole Voting Power Reporting 8. Shared Voting Power 1 36,464,575]

By | 2016-03-18T14:49:34+00:00 November 2nd, 2015|Categories: Chinese Stocks, MCOX, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar